First Tracks Biotherapeutics, Inc. (TRAX) vs Vir Biotechnology, Inc. (VIR)

First Tracks Biotherapeutics, Inc. and Vir Biotechnology, Inc. are both Biotechnology companies. First Tracks Biotherapeutics, Inc. and Vir Biotechnology, Inc. are of similar size ($1.9B and $1.9B). First Tracks Biotherapeutics, Inc. has the higher net margin (0.00% vs −61.0%) and the higher return on invested capital (0.00% vs −30.3%). Across the 10 metrics below, First Tracks Biotherapeutics, Inc. leads on 8 and Vir Biotechnology, Inc. on 2.

Valuation

Metric TRAX VIR Biotechnology median
P/E n/m n/m 10.60
P/S n/m 6.81 9.40
P/B 11.31 2.30 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 5.29 9.02
Earnings yield (10.82%) (10.24%) (32.88%)
Free cash flow yield (6.57%) (6.88%) (23.13%)

Profitability

Metric TRAX VIR Biotechnology median
Gross margin — 99.99% 68.51%
Operating margin 0.00% (69.82%) 0.00%
Net margin 0.00% (61.03%) 0.00%
Free cash flow margin 0.00% (46.87%) 0.00%
Return on equity 0.00% (21.84%) (51.96%)
Return on assets 0.00% (17.34%) (46.06%)
Return on invested capital 0.00% (30.32%) 0.00%

Growth

Metric TRAX VIR Biotechnology median
Revenue growth (TTM) — 1,695.96% 6.76%
EPS growth (last fiscal year) — 17.49% 29.88%
Revenue growth, 5-year CAGR — (2.14%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric TRAX VIR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.16 6.30 4.97
Net debt to EBITDA — 1.02 1.01

Dividend

Metric TRAX VIR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric TRAX VIR Biotechnology median
Market cap 1.91b 1.86b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack